Overview: Hepatitis A IgG TestIntroduction: The Hepatitis A IgG Test detects IgG antibodies to hepatitis A to confirm past infection or immunity, preventing liver issues. Aligned with 2023 AASLD guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding vaccination decisions, travel planning, and improving outcomes in serology for patients with suspected hepatitis A exposure.
Other Names: Anti-HAV IgG Assay, Hepatitis A Immunity Test.
FDA Status: FDA-cleared diagnostic test, meeting serology standards for diagnostic accuracy.
Historical Milestone: Hepatitis A antibody testing began in the 1970s with vaccine development. IgG immunoassays improved in the 1980s, enhancing immunity detection.
Purpose: Confirms past hepatitis A infection or immunity, guides vaccination, and monitors anti-HAV IgG in patients to prevent liver issues.
Test Parameters: 1. Hepatitis A IgG
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report history of hepatitis A, vaccination, or travel to endemic areas.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document history of hepatitis A, vaccination status, or travel to endemic areas. Include current medications and recent infections.
Consent: Written consent required, detailing the tests purpose, immunity implications, and potential need for vaccination.
Procedural Considerations: Uses an immunoassay to detect anti-HAV IgG antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper sample handling or recent vaccination can affect results. Early post-infection testing may yield false negatives.
Clinical Significance: Positive anti-HAV IgG indicates immunity from past infection or vaccination, guiding travel or vaccination decisions. Negative results suggest susceptibility.
Specialist Consultation: Consult an infectious disease specialist or hepatologist for result interpretation and vaccination planning.
Additional Supporting Tests: Anti-HAV IgM, liver function tests, or hepatitis A vaccine titers to confirm immunity status.
Test Limitations: Early post-infection testing may miss IgG. Clinical correlation is needed for vaccination decisions.
References: AASLD Hepatitis A Guidelines, 2023; Hepatology, Nelson NP, 2022.
